Naphthyridinone-aniline compounds for treatment of dermal disorders
US12378240B2 · kind B2 · utility
0Cited by
12References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 20, 2019 |
| Grant date | Aug 5, 2025 |
| Priority date | — |
| Expiry date | Jan 13, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P17/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are compounds, pharmaceutical compositions comprising the compounds, methods of preparing the compounds, and methods of using the compounds and compositions in treating diseases or disorders in a subject where the subject is in need of an inhibitor of MEK where the compound is according to formula (I): where R1, R2, R2a, R3, R3a, R3b, and subscript n are as described herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.